Mirroring the vaccine enhanced vvG/RSV model (Fig 1A), we observed an increased influx of CD4+ T cells in the lungs and airways in AvCystatin treated mice undergoing primary infection (Figs 4A, 5A and 5D). Here, CD4 is linked to infection.